Skin and Connective Tissue Diseases Clinical Trial
Official title:
A Single-Centre, Explorative, Randomised, Investigator-Blinded, Negative-Controlled, Phase I Clinical Trial With Intra-Individual Comparison of Treatments to Assess Steroid Induced Skin Atrophy on Healthy Skin
The purpose of this study is to assess steroid induced skin atrophy by sonography.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04971200 -
Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo
|
Early Phase 1 | |
| Active, not recruiting |
NCT05525741 -
Assessment of Circulating Fubctional Mitochondrias in Vitiligo Patients
|
N/A | |
| Completed |
NCT02379793 -
Skin Irritation Test of LEO 80185 Gel in Healthy Japanese Subjects
|
Phase 1 | |
| Completed |
NCT01093911 -
Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)
|
Phase 1 | |
| Completed |
NCT00147511 -
Time To Efficacy and Onset Of Action Of Linezolid
|
Phase 4 | |
| Completed |
NCT01764594 -
Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus
|
Phase 1 | |
| Active, not recruiting |
NCT05185258 -
Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study
|
Phase 4 | |
| Completed |
NCT02985437 -
Safety and Tolerability of Topically Applied Bovine Lung Surfactant on Intact Skin
|
Phase 1 | |
| Completed |
NCT02518048 -
A Psoriasis Plaque Test Trial With LEO 90100 Compared to Betesil® in Patients With Psoriasis Vulgaris
|
Phase 2 | |
| Withdrawn |
NCT03196115 -
Biomarker for Hyaline Fibromatosis Syndrome (BioHFS)
|
||
| Completed |
NCT02416258 -
A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123)
|
Phase 2 |